Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FRM F005 - The Approach to the Patient with Cutaneous T-Cell Lymphoma

Open admission to eligible categories, no tuition or ticket


Date: Friday, March 21

CME Credits: 2.00

Location: Room 201

Time: 10:00 AM - 12:00 PM

Director: Brian Poligone, MD, PhD, FAAD

  • Elaine S. Gilmore, MD, PhD, FAAD
  • Ellen J. Kim, MD, FAAD
  • Pierluigi Porcu
  • Alain H. Rook, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Evaluate patients to appropriately stage CTCL
  • Select appropriate skin directed and systemic therapies in CTCL
  • Discuss immune modifier therapy for more advanced disease and are approach to pruritus.

This session will address topics of interest to the general dermatologist and oncologist treating mycosis fugoides and Sezary syndrome (MF/SS). An overview of diagnosis and staging will be provided. Treatment options for both early and later stage disease will be covered. In addition, the forum will cover immune modifier therapy for more advanced disease. There will also be a discussion on the evaluation and treatment of pruritus in CTCL.


Friday, March 21
10:00 AMStaging MF/SS / Dr. Poligone
10:20 AMSkin Directed Therapy / Dr. Kim
10:45 AMSystemic Therapy / Dr. Porcu
11:10 AMImmune Modifier Therapy for Advanced Disease / Dr. Rook
11:35 AMManagement of Pruritus in CTCL / Dr. Gilmore